Ramelteon vs Placebo for Prevention of Delirium and Improvement of Sleep in Hospitalized Older Adults
Status:
Withdrawn
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
This study evaluates whether Ramelteon can prevent delirium, decrease the severity of
incident delirium and improve sleep wake cycle in hospitalized elderly surgical patients.
Half of the patients will be assigned to Ramelteon, while other half will be assigned to
placebo.